| An integrative model of cellular states, plasticity, and genetics for glioblastoma C Neftel, J Laffy, MG Filbin, T Hara, ME Shore, GJ Rahme, AR Richman, ... Cell 178 (4), 835-849. e21, 2019 | 1670 | 2019 |
| Splice variant–specific cellular function of the formin INF2 in maintenance of Golgi architecture V Ramabhadran, F Korobova, GJ Rahme, HN Higgs Molecular biology of the cell 22 (24), 4822-4833, 2011 | 93 | 2011 |
| Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma P Mao, MP Hever-Jardine, GJ Rahme, E Yang, J Tam, A Kodali, B Biswal, ... PLoS One 8 (11), e81803, 2013 | 85 | 2013 |
| Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function GJ Rahme, MA Israel Oncogene 34 (1), 53-62, 2015 | 71 | 2015 |
| Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: Role of β-catenin/connexin43 association RS Talhouk, MB Fares, GJ Rahme, HH Hariri, T Rayess, HA Dbouk, ... Experimental cell research 319 (20), 3065-3080, 2013 | 57 | 2013 |
| Regulatory T cells are not a strong predictor of survival for patients with glioblastoma AA Thomas, JL Fisher, GJ Rahme, TH Hampton, U Baron, S Olek, ... Neuro-oncology 17 (6), 801-809, 2015 | 51 | 2015 |
| PDGF engages an E2F-USP1 signaling pathway to support ID2-mediated survival of proneural glioma cells GJ Rahme, Z Zhang, AL Young, C Cheng, EJ Bivona, SN Fiering, ... Cancer research 76 (10), 2964-2976, 2016 | 47 | 2016 |
| Pediatric brain tumors: current knowledge and therapeutic opportunities J Glod, GJ Rahme, H Kaur, EH Raabe, EI Hwang, MA Israel Journal of pediatric hematology/oncology 38 (4), 249-260, 2016 | 44 | 2016 |
| MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation JR Howe, ES Li, SE Streeter, GJ Rahme, E Chipumuro, GB Russo, ... PLoS One 12 (5), e0177661, 2017 | 37 | 2017 |
| ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function Z Zhang, GJ Rahme, PD Chatterjee, MC Havrda, MA Israel Cell death & disease 8 (2), e2615-e2615, 2017 | 33 | 2017 |
| Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma AA Thomas, JL Fisher, TH Hampton, BC Christensen, GJ Tsongalis, ... Cancer Immunology, Immunotherapy 66, 379-389, 2017 | 28 | 2017 |
| Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein TW Jenkins, SL Downey-Kopyscinski, JL Fields, GJ Rahme, WC Colley, ... Scientific Reports 11 (1), 10883, 2021 | 23 | 2021 |
| A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma GJ Rahme, BW Luikart, C Cheng, MA Israel Neuro-oncology 20 (3), 332-342, 2018 | 22 | 2018 |
| Parallel single-cell RNA-seq and genetic recording reveals lineage decisions in developing embryoid bodies IS Kim, J Wu, GJ Rahme, S Battaglia, A Dixit, E Gaskell, H Chen, L Pinello, ... Cell reports 33 (1), 2020 | 18 | 2020 |
| Modeling epigenetic lesions that cause gliomas GJ Rahme, NM Javed, KL Puorro, S Xin, V Hovestadt, SE Johnstone, ... Cell 186 (17), 3674-3685. e14, 2023 | 11 | 2023 |
| Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution KL Kim, P van Galen, V Hovestadt, GJ Rahme, EN Andreishcheva, ... Cell reports methods 1 (5), 2021 | 10 | 2021 |
| Gap junctions mediate STAT5-independent β-casein expression in CID-9 mammary epithelial cells RS Talhouk, AA Khalil, R Bajjani, GJ Rahme, ME El-Sabban Cell communication & adhesion 18 (5), 104-116, 2011 | 6 | 2011 |
| Brain Tumors S Kesari, GJ Rahme, DA Almiron, MA Israel Schwab 5, 16, 2016 | 1* | 2016 |
| STK17A is a potential therapeutic target in glioblastoma P Mao, MP Jardine, GJ Rahme, EC Yang, J Tam, A Kodali, B Biswal, ... Cancer Research 74 (19_Supplement), 4605-4605, 2014 | 1 | 2014 |
| Dissection of a CTCF topological boundary uncovers principles of enhancer-oncogene regulation KL Kim, GJ Rahme, VY Goel, CA El Farran, AS Hansen, BE Bernstein Molecular Cell 84 (7), 1365-1376. e7, 2024 | | 2024 |
Bradley BernsteinProfessor of Pathology, Harvard UniversityVerified email at broadinstitute.org
